Devonian Health Group Inc.

Quebec City – October 16, 2026 -- Devonian Health Group Inc. (TSXV: GSD; OTCQB: DVHGF) has not set a revised trading start date or closing date for its planned U.S. initial public offering on the NYSE American, according to its third update on the process since July 27, 2026.

Devonian keeps ThinkEquity on the NYSE American IPO preparations

The company said it continues to work with ThinkEquity on the steps needed to complete the offering and list its common shares and warrants on the NYSE American. The proposed ticker symbols are "DHGR" for the shares and "DHGR WS" for the warrants.

The latest statement follows earlier updates dated August 18, 2026, and September 11, 2026. Devonian said it will announce the revised trading and closing dates by press release once they are determined.

Quebec – September 17, 2026 -- Devonian Health Group Inc. (TSXV: GSD) (OTCQB: DVHGF) expects its common shares and warrants to begin trading on NYSE American LLC as early as September 17, 2026, under the ticker symbols "DHGR" and "DHGR WS."

Devonian pursues dual listing tied to underwritten public offering

The proposed NYSE American listing is connected to an underwritten public offering of Devonian's common shares and warrants. The company will retain its existing listing on the TSX Venture Exchange and has reserved the symbol "DHGR" there, with plans to later change its TSXV ticker from "GSD" to "DHGR."

Listing remains contingent on NYSE American's final authorization

Trading commencement on NYSE American depends on market conditions and final approval of Devonian's listing application, as well as the company's continued compliance with exchange rules.